<DOC>
	<DOCNO>NCT01722175</DOCNO>
	<brief_summary>This randomized phase II trial compare well associate liver partition portal vein ligation stag hepatectomy ( ALPPS ) portal vein occlusion ( PVO ) work treat patient liver cancer . Both treatment type 2-stage hepatectomies remove liver cancer . ALPPS may effective PVO patient whose disease would traditionally consider inoperable .</brief_summary>
	<brief_title>Associating Liver Partition With Portal Vein Ligation For Staged Hepatectomy ( ALPPS ) Portal Vein Occlusion Treating Patients With Liver Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Patient may primary secondary hepatic malignancy FLR/TLV &lt; 30 % FLR/BW ratio &lt; 0.5 patient normal liver function ( define normal transaminase , normal bilirubin , normal factor V , normal PT/INR ) . In case injury due chemotherapy , know high grade steatosis , cholestasis &gt; 50 mmol/L , patient may enrol trial FLR/TLV &lt; 40 % FLR/BW ratio &lt; 0.8 . Patient must extensive liver tumor would require portal vein embolization twostage hepatectomy portal vein embolization ligation judgment surgeon tumor board . Patient may extrahepatic disease long may address liver surgery tumor board decision proceed liver resection ( mostly applicable CRC metastasis ) . Patient may receive previous chemotherapy . In case cholestasis , preoperative drainage procedure ( PTC ERCP ) leave judgement physician . Patient must â‰¥ 18 year age . The patient population 65 year old need carefully include base comorbidities . Patient may undergo previous liver resection . Patient 's location must proper stag followup may perform . Patient 's case must present Multidisciplinary Meeting attend hepatobiliary surgeon , oncologist , hepatologists , radiologist , must approve directly Dr. Strasberg Dr. Chapman . Patient must able understand willing sign write informed consent document . Patient must significant concomitant disease render him/her unsuitable major liver surgery judgment physician involve , especially patient &gt; 65 year old . Patient must enrol clinical trial within 4 week study entry . Patient must peritoneal carcinomatosis extensive extrahepatic disease . Patient must advance stage carcinoma gallbladder ( T3/T4 ) Patient must issue drug and/or alcohol abuse . Patient must need major extrahepatic surgery ( e.g . pancreas resection , gastric resection , rectal surgery ) within 3 month study entry . Patient must candidate liver transplantation case HCC . Patient must pregnant breastfeeding . If female childbearing potential , patient must negative pregnancy test within 14 day enrollment . Inclusion Women Minorities Both men woman member race ethnic group eligible trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>